These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23159297)

  • 1. Limitations in qualitative point of care hCG tests for detecting early pregnancy.
    Greene DN; Schmidt RL; Kamer SM; Grenache DG; Hoke C; Lorey TS
    Clin Chim Acta; 2013 Jan; 415():317-21. PubMed ID: 23159297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical sensitivity of four commonly used hCG point of care devices.
    Kamer SM; Foley KF; Schmidt RL; Greene DN
    Clin Biochem; 2015 Apr; 48(6):448-52. PubMed ID: 25549977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy.
    Cervinski MA; Lockwood CM; Ferguson AM; Odem RR; Stenman UH; Alfthan H; Grenache DG; Gronowski AM
    Clin Chim Acta; 2009 Aug; 406(1-2):81-5. PubMed ID: 19477170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening method to evaluate point-of-care human chorionic gonadotropin (hCG) devices for susceptibility to the hook effect by hCG β core fragment: evaluation of 11 devices.
    Nerenz RD; Song H; Gronowski AM
    Clin Chem; 2014 Apr; 60(4):667-74. PubMed ID: 24463559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Hook-like effect" causes false-negative point-of-care urine pregnancy testing in emergency patients.
    Griffey RT; Trent CJ; Bavolek RA; Keeperman JB; Sampson C; Poirier RF
    J Emerg Med; 2013 Jan; 44(1):155-60. PubMed ID: 21835572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Background hCG in non-pregnant individuals: need for more sensitive point-of-care and over-the-counter pregnancy tests.
    Cole LA; Ladner DG
    Clin Biochem; 2009 Feb; 42(3):168-75. PubMed ID: 18929550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of a false positive urine pregnancy test in a patient with membranoproliferative glomerulonephritis type I.
    Marzinke MA; Jarrar P; Atkinson M; Humphrey RL; Detrick B; Sokoll LJ
    Clin Chim Acta; 2012 Jan; 413(1-2):361-3. PubMed ID: 22024216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference.
    Milhorn D; Korpi-Steiner N
    Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need for a quantitative urine hCG assay.
    Cole LA; Khanlian SA
    Clin Biochem; 2009 May; 42(7-8):676-83. PubMed ID: 19026624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment.
    Gronowski AM; Cervinski M; Stenman UH; Woodworth A; Ashby L; Scott MG
    Clin Chem; 2009 Jul; 55(7):1389-94. PubMed ID: 19395437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of pregnancy test false negative results due to elevated levels of β-core fragment hCG.
    Johnson S; Eapen S; Smith P; Warren G; Zinaman M
    J Immunoassay Immunochem; 2017; 38(4):449-455. PubMed ID: 28521601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the beta-Neocept test for early pregnancy.
    Yuen BH; Pride SM; Callegari PB
    Can Med Assoc J; 1984 Sep; 131(6):583-5. PubMed ID: 6206935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-Negative Urine Human Chorionic Gonadotropin Testing in the Clinical Laboratory.
    Herskovits AZ; Chen Y; Latifi N; Ta RM; Kriegel G
    Lab Med; 2020 Jan; 51(1):86-93. PubMed ID: 31245816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of qualitative urinary hCG assays.
    Nickmans S; Vermeersch P; Van Eldere J; Billen J
    Acta Clin Belg; 2014 Aug; 69(4):277-9. PubMed ID: 24846178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical performance evaluation of the i-STAT Total β-human chorionic gonadotropin immunoassay.
    Sowder AM; Yarbrough ML; Nerenz RD; Mitsios JV; Mortensen R; Gronowski AM; Grenache DG
    Clin Chim Acta; 2015 Jun; 446():165-70. PubMed ID: 25916696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single serum test for measuring early pregnancy outcome with high predictive value.
    Sutton-Riley JM; Khanlian SA; Byrn FW; Cole LA
    Clin Biochem; 2006 Jul; 39(7):682-7. PubMed ID: 16765931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum human chorionic gonadotropin concentrations greater than 400,000 IU/L are invariably associated with suppressed serum thyrotropin concentrations.
    Lockwood CM; Grenache DG; Gronowski AM
    Thyroid; 2009 Aug; 19(8):863-8. PubMed ID: 19505185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performances of urine pregnancy tests on College of American Pathologists Survey specimens.
    Biesecker JL; Rippey JH
    Am J Clin Pathol; 1981 Oct; 76(4 Suppl):544-6. PubMed ID: 7282640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molar pregnancy with false negative urine hCG: the hook effect.
    Pang YP; Rajesh H; Tan LK
    Singapore Med J; 2010 Mar; 51(3):e58-61. PubMed ID: 20428735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative evaluation of ELISA and latex agglutination tests for detection of human chorionic gonadotropin (hCG) in urine for pregnancy.
    Ambedkar SS; Deshpande BS; Naik SR
    Hindustan Antibiot Bull; 1988; 30(1-2):12-5. PubMed ID: 3170256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.